Varex Imaging Corporation (VREX)
USD 10.32
(-9.76%)
USD 10.32
(-9.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 67.2 Million USD | -39.08% |
| 2023 | 110.3 Million USD | -28.11% |
| 2022 | 123.6 Million USD | 19.24% |
| 2021 | 112.4 Million USD | 288.03% |
| 2020 | -1.7 Million USD | -179.32% |
| 2019 | 83.9 Million USD | 0.0% |
| 2018 | 89.7 Million USD | -45.58% |
| 2017 | 111.1 Million USD | -28.72% |
| 2016 | 122.2 Million USD | -13.39% |
| 2015 | 141.1 Million USD | -23.81% |
| 2014 | 185.2 Million USD | 1.87% |
| 2013 | 180.6 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 16.3 Million USD | -1.21% |
| 2024 Q1 | 14.7 Million USD | -61.03% |
| 2024 Q2 | 16.5 Million USD | 27.91% |
| 2023 Q2 | 15.1 Million USD | 17.05% |
| 2023 Q1 | 12.9 Million USD | -45.11% |
| 2023 Q4 | 8.2 Million USD | -74.45% |
| 2023 FY | - USD | -28.11% |
| 2023 Q3 | 32.1 Million USD | 112.58% |
| 2022 Q1 | 21.3 Million USD | -16.8% |
| 2022 FY | - USD | 19.24% |
| 2022 Q4 | 23.5 Million USD | 2.62% |
| 2022 Q3 | 22.9 Million USD | -27.07% |
| 2022 Q2 | 31.4 Million USD | 47.42% |
| 2021 FY | - USD | 288.03% |
| 2021 Q4 | 25.6 Million USD | -1.16% |
| 2021 Q2 | 22.7 Million USD | 305.36% |
| 2021 Q3 | 25.9 Million USD | 14.1% |
| 2021 Q1 | 5.6 Million USD | 137.09% |
| 2020 Q1 | 4.2 Million USD | -73.08% |
| 2020 Q3 | -30.2 Million USD | -962.86% |
| 2020 Q4 | -15.1 Million USD | 50.0% |
| 2020 FY | - USD | -179.32% |
| 2020 Q2 | 3.5 Million USD | -16.67% |
| 2019 Q1 | 9.2 Million USD | 67.27% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | 15.6 Million USD | 246.67% |
| 2019 Q3 | 4.5 Million USD | -66.17% |
| 2019 Q2 | 13.3 Million USD | 44.57% |
| 2018 FY | - USD | -45.58% |
| 2018 Q4 | 5.5 Million USD | -31.25% |
| 2018 Q1 | 12.6 Million USD | -49.19% |
| 2018 Q2 | 21.3 Million USD | 69.05% |
| 2018 Q3 | 8 Million USD | -62.44% |
| 2017 Q3 | 20 Million USD | -14.53% |
| 2017 FY | - USD | -28.72% |
| 2017 Q1 | 23.3 Million USD | -35.81% |
| 2017 Q2 | 23.4 Million USD | 0.43% |
| 2017 Q4 | 24.8 Million USD | 24.0% |
| 2016 Q1 | 25.5 Million USD | -14.43% |
| 2016 Q2 | 28.7 Million USD | 12.55% |
| 2016 Q4 | 36.3 Million USD | 14.87% |
| 2016 Q3 | 31.6 Million USD | 10.1% |
| 2016 FY | - USD | -13.39% |
| 2015 FY | - USD | -23.81% |
| 2015 Q4 | 29.8 Million USD | 0.0% |
| 2014 FY | - USD | 1.87% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 598.258% |
| Cerus Corporation | -26.53 Million USD | 353.241% |
| OrthoPediatrics Corp. | -8.38 Million USD | 901.814% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 740.336% |
| Talis Biomedical Corporation | -66.04 Million USD | 201.749% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 502.999% |
| Inogen, Inc. | -45.67 Million USD | 247.114% |
| Spectral AI, Inc. | -12.26 Million USD | 648.035% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 240.901% |
| CVRx, Inc. | -38.73 Million USD | 273.504% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 2004.762% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 655.051% |
| Orthofix Medical Inc. | -86.98 Million USD | 177.255% |
| Venus Concept Inc. | -26.11 Million USD | 357.343% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 235.018% |
| Bioventus Inc. | -23.07 Million USD | 391.287% |
| BrainsWay Ltd. | -2.31 Million USD | 3007.832% |
| Envoy Medical, Inc. | -18.23 Million USD | 468.461% |
| electroCore, Inc. | -17.76 Million USD | 478.378% |
| IceCure Medical Ltd | -15.25 Million USD | 540.569% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 235.073% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 498.678% |
| MaxCyte, Inc. | -44.12 Million USD | 252.284% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 671.624% |
| Nexalin Technology, Inc. | -5.69 Million USD | 1280.596% |
| PAVmed Inc | -75.74 Million USD | 188.722% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 225.005% |
| RxSight, Inc. | -41.03 Million USD | 263.755% |
| Sight Sciences, Inc. | -49.41 Million USD | 235.991% |
| SI-BONE, Inc. | -34.44 Million USD | 295.088% |
| TELA Bio, Inc. | -40.63 Million USD | 265.383% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 215.27% |
| Treace Medical Concepts, Inc. | -39 Million USD | 272.272% |
| LivaNova PLC | 39.01 Million USD | -72.237% |
| 908 Devices Inc. | -34.02 Million USD | 297.502% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 160.764% |
| Nemaura Medical Inc. | -7.28 Million USD | 1022.183% |
| NeuroPace, Inc. | -22.83 Million USD | 394.298% |
| LENSAR, Inc. | -8.71 Million USD | 871.173% |
| Apyx Medical Corporation | -18.11 Million USD | 471.025% |
| Cutera, Inc. | -136.56 Million USD | 149.209% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 2088.166% |
| BioSig Technologies, Inc. | -28.15 Million USD | 338.713% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -2570.906% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 420.168% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 82.48% |
| Axonics, Inc. | 7.77 Million USD | -764.309% |
| Outset Medical, Inc. | -153.78 Million USD | 143.696% |
| IRIDEX Corporation | -7.44 Million USD | 1002.256% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 168.505% |
| IRadimed Corporation | 20.8 Million USD | -223.067% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 933.54% |
| INVO Bioscience, Inc. | -6.88 Million USD | 1076.741% |
| Telesis Bio, Inc. | -40.49 Million USD | 265.955% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -83.221% |
| Quipt Home Medical Corp. | 44.07 Million USD | -52.481% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 718.215% |
| Pulmonx Corporation | -55.09 Million USD | 221.978% |
| Dynatronics Corporation | -976 Thousand USD | 6985.189% |
| Modular Medical, Inc. | -17.1 Million USD | 492.914% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 563.928% |
| Semler Scientific, Inc. | 23.58 Million USD | -184.879% |
| InMode Ltd. | 196.28 Million USD | 65.764% |
| Bruker Corporation | 599 Million USD | 88.781% |
| Cytosorbents Corporation | -28.81 Million USD | 333.246% |
| DexCom, Inc. | 916.7 Million USD | 92.669% |
| Align Technology, Inc. | 799.03 Million USD | 91.59% |
| Viveve Medical, Inc. | -20.61 Million USD | 425.945% |
| ZimVie Inc. | 91.07 Million USD | 26.213% |
| Movano Inc. | -29.12 Million USD | 330.73% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 1624.501% |
| Nexalin Technology, Inc. | -5.69 Million USD | 1280.596% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 2004.762% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 134.522% |
| Profound Medical Corp. | -27.12 Million USD | 347.756% |
| Insulet Corporation | 323.6 Million USD | 79.234% |
| enVVeno Medical Corporation | -25.01 Million USD | 368.607% |
| Surmodics, Inc. | 1.18 Million USD | -5556.566% |
| iCAD, Inc. | -6.56 Million USD | 1123.61% |
| Nuwellis, Inc. | -16.35 Million USD | 510.858% |
| Biotricity, Inc. | -8.82 Million USD | 861.191% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 169.377% |
| Aethlon Medical, Inc. | -11.84 Million USD | 667.131% |
| InspireMD, Inc. | -20.91 Million USD | 421.362% |
| PAVmed Inc. | -75.74 Million USD | 188.722% |
| BIOLASE, Inc. | -15.13 Million USD | 543.887% |
| Beyond Air, Inc. | -59.03 Million USD | 213.838% |
| FONAR Corporation | 28.25 Million USD | -137.863% |
| AxoGen, Inc. | -13.32 Million USD | 604.202% |
| Vivani Medical, Inc. | -26.6 Million USD | 352.556% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -173.827% |
| Inari Medical, Inc. | 7.11 Million USD | -844.749% |
| UFP Technologies, Inc. | 72.74 Million USD | 7.62% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 2084.768% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 1191.619% |
| Tenon Medical, Inc. | -15.52 Million USD | 532.767% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 540.194% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 262.022% |
| AdaptHealth Corp. | -171.09 Million USD | 139.277% |
| Sintx Technologies, Inc. | -6.6 Million USD | 1118.182% |
| NanoVibronix, Inc. | -3.43 Million USD | 2056.332% |
| Quanterix Corporation | -38.08 Million USD | 276.434% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 718.215% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -223900.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 124.235% |
| TransMedics Group, Inc. | -7.6 Million USD | 983.862% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 408.753% |
| NeuroMetrix, Inc. | -7.09 Million USD | 1047.038% |
| Hyperfine, Inc. | -47.06 Million USD | 242.793% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 215.252% |
| Biomerica, Inc. | -5.99 Million USD | 1221.308% |
| Bone Biologics Corporation | 479.57 Thousand USD | -13912.494% |
| AVITA Medical, Inc. | -39.56 Million USD | 269.835% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 832.59% |
| Silk Road Medical, Inc | -45.08 Million USD | 249.068% |